Marker Therapeutics Inc. Stock News

Sprint (NYSE:S) +74% after judge approves T-Mobile merger.Rexahn Pharmaceuticals (NASDAQ:REXN) +25%.ZK International Group (NASDAQ:ZKIN) +21% on supplying stainless steel pipe and fitting products f

Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological ma

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie

The nature of investing is that you win some, and you lose some. And unfortunately for Marker Therapeutics, Inc...

Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research show

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharma

Conference Call and Webcast Today at 5:00pm EST HOUSTON , Nov. 12, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the developme

HOUSTON , Nov. 11, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapie

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge

The union warns further walk outs could happen 'until they receive assurances that the bullying will stop and their concerns are fairly addressed'

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

HOUSTON , Aug. 15, 2019   /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunothe

Berlin-based Neufund, an end to end security token platform, is set to host Europe's first primary issuance of tokenized equity that is offered to the general p

Neufund, a Berlin-based coding project on the Ethereum blockchain, is celebrating a pre-sale funding round of $11.6 million (€10 million). Backed by top priv